Neuroprotection by Drugs, Nutraceuticals and Physical Activity
- PMID: 36834601
- PMCID: PMC9959052
- DOI: 10.3390/ijms24043176
Neuroprotection by Drugs, Nutraceuticals and Physical Activity
Abstract
Acute and chronic neural injuries, including stroke, brain trauma and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), Parkinson's disease (PD), and Alzheimer's disease (AD) are associated with high morbidity and mortality rates [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Lillo A., Raïch I., Lillo J., Pérez-Olives C., Navarro G., Franco R. Expression of the Adenosine A2A-A3 Receptor Heteromer in Different Brain Regions and Marked Upregulation in the Microglia of the Transgenic APPSw, Ind Alzheimer’s Disease Model. Biomedicines. 2022;10:214. doi: 10.3390/biomedicines10020214. - DOI - PMC - PubMed
-
- Zhi W.-J., Qiao S.-M., Zou Y., Peng R.-Y., Yan H.-T., Ma L.-Z., Dong J., Zhao L., Yao B.-W., Zhao X.-L., et al. Low P-SYN1 (Ser-553) Expression Leads to Abnormal Neurotransmitter Release of GABA Induced by Up-Regulated Cdk5 after Microwave Exposure: Insights on Protection and Treatment of Microwave-Induced Cognitive Dysfunction. Curr. Issues Mol. Biol. 2022;44:206–221. doi: 10.3390/cimb44010015. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
